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Abstract
Targeted genomic inversion 
using zinc finger nucleases : 
Toward gene therapy for Haemophilia A
Jiyeon Kweon
Biochemistry, Department of Chemistry
The Graduate School
Seoul National University
  As whole genome sequencing technology develops rapidly, there are 
many reports about structural variation in genome. Structural variations, 
which include insertions, deletions, duplications, translocations and 
inversions, occur in more wide region of genome than single-nucleotide 
polymorphisms. These structural variations are found in normal 
populations of human in some cases, but these are the cause of many 
genetic diseases. Especially, Haemophilia A and Hunter syndrome are 
2
caused by genomic inversion.
  For this reasons, structural variations are highly regarded in the fields 
of therapy of genetic disorders. Despite the importance of structural 
variations, it is difficult to investigate the mechanism of these, because 
there are no molecular tools to induce structural variations in genome.
  Here in this study, inducements of genomic inversions in human 
genomes are attempted using zinc finger nuclease technology. Zinc 
finger nucleases are made to induce genomic inversions in the region 
of Intron 1 of F8 gene-cause of severe Haemophilia A-and validated by 
various methods. Theses results hold new promises for the gene therapy 
of Haemophilia A and it is hoped that zinc finger nuclease technologies 
are widely used in the fields of gene therapy, based on this study.
Keywords : zinc finger nuclease (ZFN), double-strand break 
(DSB), structural variation(SVs), genomic inversion, Haemophilia A, F8 
gene.
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I. Introduction
  Zinc finger nucleases (ZFNs) are artificial restriction enzymes which 
can induce sequence-specific double-strand breaks (DSBs) in targeted 
genomic region. From this point of view, ZFNs are used as powerful 
tools for gene therapy. 
  Haemophilia A is genetic disorders that caused by deficiency of 
blood coagulation factor VIII (F8). The reasons of F8 deficiency are 
various and intron1 of F8 gene-related inversion accounts for about 5% 
of them.(Bagnall et al. 2002) Many researchers focus on Haemophilia 
A as good models of gene therapy. First, Haemophilia A is genetic 
disorders which cause by defect of single gene, F8 gene. Second, only 
few amounts of compensation of coagulation factor VIII are sufficient 
to moderate the bleeding phenotype. In murine models, Xu et al. shown 
that transplantation of iPSCs which express the F8 to the haemophilia 
A mice is effective to moderate bleeding phenotype and prolong the 
life of mice.(Xu et al. 2009)
  As the murine models, this approach will be applied in human. 
Recently, it is possible to produce patient-specific induced pluripotent 
stem cells. For cell therapy, ZFN-mediated gene corrections in 
patients-derived cells are performed and the gene corrected cells are 
transplanted to patients again. This method has benefits that the 
gene-corrected cells are originated from patients himself, so there are 
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few or no risk of immune rejection. 
  This ZFN-mediated cell therapy has benefit compare with current 
Haemophilia A therapy. The protein replacements therapy has some 
problems related to contamination of other proteins and the cost of that 
therapy is very expensive. (Youjin and Jun 2009) Viral vector-mediated 
gene transfer therapy also has the risk of genome integration, immune 
rejection. 
  In this study, ZFN-mediated genomic inversions in intron1 of F8 
gene are performed in cultured human cells and primary human blood 
cells. This results open up the possibilities that ZFN can be used as 
powerful tools for gene therapy.
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II. Materials and Methods
1. Plasmid construction
(a) Zinc finger nucleases.
  Plasmid encoding ZFNs targeting intron 1 of F8 gene region were 
constructed by modular assembly as described previously.(Kim et al. 
2009; Kim et al. 2011b) Various FokI domains were used in this 
study.(Miller et al. 2007; Szczepek et al. 2007; Doyon et al. 2011; Guo 
et al. 2010)
2. Cell culture and transfection method
  Human embryonic kidney 293T/17 (ATCC, CRL-11268TM) cells 
were maintained in Dulbecco's modified Eagle medium (Welgene 
Biotech) supplemented with fetal bovine serum (10%), penicillin (100 
units/ml), and streptomycin (100ug/ml) at 37 °C and 5% CO2. 
2x105Cell were seeded at 24-well plate, incubated for 20~24 hours, and 
then transfected with plasmid DNA using polyethylenimine. Genomic 
DNA are isolated using the G-DEXTM IIc Genomic DNA Extraction Kit 
(iNtRON, cat#17231) as described by the manufacturer's protocol.
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3. T7 endonuclease I assay.
  T7 endonuclease I assay protocols were based on previous study.(Kim 
et al. 2009) The genomic region encompassing the ZFN target site was 
amplified using appropriated primer sets, usually hemi nested or nested 
PCR method. The PCR products were melted and annealed to form 
hetero-duplex DNA. The melting/annealing were done using PCR 
machine.(95℃ 2min, -2℃/s to 85℃, -0.1℃/s to 25℃) The annealed 
DNA was treated with T7 endonuclease 1 for 20 min at 37 °C and 
analyzed 2% agarose gel assay. 
4. PCR analysis of genomic inversion and sequencing of 
breakpoint junctions.
  Genomic DNA were quantified by Nanodrop and usually 100ng were 
used to PCR analysis. Nested PCR was performed to efficient 
amplification. For sequencing analysis, PCR products were purified and 
cloned into the T-Blunt vector using the T-Blunt PCR Cloning Kit 
(SolGent). The colonies were analyzed by colony PCR and 
appropriate-sized colonies were inoculated and plasmid DNA were 
extracted. Then the plasmid DNA were sequenced using appropriated 
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primers.
5. Estimation of inversion frequencies.
  Digital PCR analysis was performed based on our previous study(Lee 
et al. 2010). Genomic DNA samples were quantified using Nanodrop 
and serially diluted with Tris-EDTA buffer. The serially diluted 
genomic DNA were amplified using appropriate primer sets. The 
frequencies of inversion were calculated using Extreme Limiting 
Dilution Analysis software(Hu and Smyth 2009).
6. Isolation of single clones.
  ZFNs encoding plasmids were transfected using Lipofectamine 2000 
in HEK 293T/17. After 3days, cells were seeded in 96-well plates at a 
density of 30 cells per well. When each wells reached appropriated 
confluency, each wells were split to two population, one of which was 
used PCR analysis to select inversion positive pools. The inversion 
positive pools were liming dilution in 96-well plates at a density of 
0.4cells per well on average. After about 2 weeks, there were colonies 
in some wells and the colonies were expanded in large wells and a 
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portion of cells were harvested to PCR analysis to confirm inversion 
positive single clones.
7. Genomic DNA preparation from Haemophilia A 
patients.
  Seoul National University Institutional Review Board(SNUIRB) 
approval was obtained for the analysis performed in this study. Blood 
sample of Haemophilia A patients was obtained at Korea Haemophilia 
Foundation Clinic and genomic DNA was obtained using QIAamp DNA 
blood Maxi kit. 
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III. Results and Discussion
1. Construction and validation of ZFNs
  As discussed above, there are two type of inversion in severe 
Haemophilia A patients. One is intron22 of F8 gene-related inversion 
and the other is intron1 of F8 gene-related inversion. Intron22-related 
inversion cases are more common but in this cases genomic inversion 
events occur between about 600kb distant region. Intron1-related 
inversion occur between about 140kb distant region, which is shorter 
than intron22-related inversion, is focused in this study. 
  To induce genomic inversion, there must be two DSBs each in the 
two homologous region, homolog1 and homolog 2.(Figure 1) The two 
homologous regions are near identical in respect of nucleotide 
sequences, only one pairs of ZFNs are necessary to induce two DSBs 
in that region. To construct ZFNs, a computer algorithm(Toolgen, Inc.) 
is used to find potential target sites of ZFNs in the 1041bp 
homologous sequences. The parameters to construct ZFNs are listed 
below. (i) 3finger or 4 finger in half-target site, (ii) spacer lengths, 
between the two half-target sites, are 5bp or 6bp. Under this 
parameters, 53 pairs of ZFNs were designed in designated the 1041bp 
homologous region. All of them were synthesis by modular assembly 
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method.(Kim et al. 2011b) 
  To validate the ability of ZFNs to induce genomic inversion in 
targeted locus, PCR method which is specific to intron1-related 
inversion is used.(Bagnall et al. 2002) As listed in Figure 2, There are 
four combination of primer sets. Before inversion evens occur, F1+R1 
and F2+R2 primer pairs are used to amplify normal genomic regions. 
When ZFN-mediated inversion events occur, F1+R1 and F2+R2 primer 
pairs cannot amplify any genomic regions but F1+F2, R1+R2 primer 
pairs really can amplify inverted genomic regions. 
  To identify which ZFN pairs can induce inversion between the 
homologous region, All of 53 pairs of ZFNs were trasnfected in HEK 
293 T/17 cells according the protocol discussed in Materials and 
Methods. Each 53 kinds of genomic DNAs are isolated and used to 
PCR templates. The templates of negative control are isolated from 
empty vector transfected cells. 
  The genomic DNAs from 6 pairs of ZFNs were amplified by the 
two inversion-specific PCR primer sets.(Figure 3) As well as 
inversion-specific PCR primer sets, F1+R1 and F2+R2 primer sets, 
which can amplify normal genomic DNA region, also can amplify all 
that 6 types of genomic DNAs.(data not shown) This means that 
inverted and normal gemonic DNA are mixed in ZFN-treated cells. The 
inverted portion of that are depend on the efficiency of ZFNs. As well 
as efficiency of ZFNs, the number of chromosomes affects the 
frequency of inversion. According to previous study(Bylund et al. 
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2004), there are hyper-copies of chromosomes in HEK 293 cells. The 
F8 gene locates in the X chromosome and there are three copies of X 
chromosomes in HEK 293 cells. 
  To identify cellular toxicity of ZFNs which can induce inversion, 
each ZFNs treated-cells were maintained and harvested in time course. 
As listed Figure 4., the genomic DNAs were isolated at 2day, 4day, 
6day after transfection. The genomic DNAs from each time points were 
used template and inversion-specific PCR were performed. 
  At the time point of 2day-post-transfection, All of 6 types of 
genomic DNAs are positive to inversion-specific PCR screening.(Figure 
4) The PCR products were analyzed by agarose gel eletrophoresis. The 
two sets of inversion-specific PCR primer pairs were used and only 
one sets of that were shown in Figure 4. All PCR analysis were 
performed with 100ng of genomic DNA and with same cycles, so the 
band intensity of each PCR products indicated the amounts of inverted 
genomic DNA indirectly. As see in Figure 4., ZFN 4, ZFN 10 and 
ZFN 53 treated genomic DNA shown relatively high intensity and ZFN 
5 treated genomic DNA shown weak intensity compare with others. 
  At the time point of 4day-post-transfection, ZFN 5, ZFN 13 and 
ZFN 45 treated genomic DNA shown very weak intensity compare with 
their intensity of 2day-post-transfection. This means that these ZFNs has 
cellular toxicity, specially cased by off-target.(Kim et al. 2009) 
  At the time point of 6day-post-transfection, genomic DNA from ZFN 
5 treated cells had no more inversion-specific bands. According to the 
14
results, ZFN 4 and ZFN 10 has less cellular toxicity than others. 
2. Improvements of ZFN specificity and activity.
  As discussed above, ZFNs had cellular toxicity and the desired 
events were disappeared within few days if the ZFN had high cellular 
toxicity. To overcome that problems, many researchers made an 
effort.(Miller et al. 2007; Szczepek et al. 2007; Guo et al. 2010; 
Doyon et al. 2011) Each groups engineered FokI nucleases domains to 
reduce homo-dimerization. These improved forms of FokI nucleases 
domains were usually named to "Obligate hetero-dimer" forms. In this 
study among many obligate hetero-dimer forms, the "sharkey" variants, 
which made by Guo et al., were used to improve the activity and 
specificity of ZFN. The "sharkey" variants were made by directed 
evolution of FokI cleavage domains to improve activity of ZFNs and 
the cellular toxicity of that variants were measured by well-established 
assay, phosphorylated histone H2AX staining, and there were no cost 
effects of off-target cleavages. 
  The amino acid sequences of Fok1 variants are listed in Table 2. 
Theses FokI variants were cloned by site-directed mutagenesis method. 
Among 6 pairs of above ZFNs, ZFN 10 was selected to test FokI 
variants. 
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  As listed in Figure 5., Left-sharkey RR and Right-sharkey DAS 
combination (donated RD in Fgure 5.) shown improved activity and 
less cellular toxicity than FokI wild type. The designated 30 degree 
menas that ZFN treated cells were incubated 1day in 37 degree 
followed 2day in 30 degree.(Doyon et al. 2010) The DS variants shown 
~4% of local mutation frequencies according to T7 endonucleases assay.
  Next, the junction sequences that indicated in Figure 1 were obtained 
according to the protocols in Materials and Methods. The 
inversion-specific PCR products were cloned into T-blunt vector and the 
plasmid DNAs were isolated from each colonies. Sequencing analysis of 
each colonies shown that many of them were perfect joined after 
inverted and some of them had indels, which were the common 
patterns of  ZFN-mediated mutation.(Figure 6) 
3. Frequency of ZFN-induced inversion and clonal 
assay.
  The frequency of ZFN-induced inversion was measured by digital 
PCR method. As described in Figure 7., 3day-post transfected and 17 
day-post transfected genomic DNA were used to identify frequencies of 
inversion. The estimated frequencies of inversion were 0.1~0.3% in 
3day-post transfected genomic DNA and that frequencies were 10 times 
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more higher than in 17 day-post transfected genomic DNA. The exact 
frequencies of inversion were calculated using ELDA software.(Hu and 
Smyth 2009) 
  As described in Materials and Methods, inversion positive single 
clones were isolated. Three independent clones were obtained and each 
clones were confirmed by PCR and sequencing analysis.(Figure 8.) The 
two clones out of three shown perfect joint junction sequences in the 
two breakpoint junctions, and one clone had two base pair deleted 
sequences in junction 1. As there are three copies of X chromosome in 
HEK 293 cells, all of three clones contained wild type allele. 
4. Inducing inversion in primary human blood cells.
  As described above, it was confirmed that ZFN-mediated genomic 
inversion were possible in cultured human cells. In theory, this same 
ZFN pair could be used to revert the inverted genomic region of 
haemophilia A patient. That is, cells from haemophilia A patient are 
treated with ZFN so as to induce reversion the inverted genomic 
region. And then, the gene corrected cells are transferred to the patient 
again, especially through iPSCs (induced-pluripopent stem cell) 
technology, to produce deficient F8 clotting factors. 
  To approach that theory, ZFN-mediated genomic inversion was 
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performed in primary human blood cells. Human blood cells were good 
sources to make iPSCs, so ZFN-mediated genomic inversion was 
performed in that cells. Blood cells from Haemophilia A patients are 
best source of this study, as gene corrected cells were used directly to 
make iPSCs and used in ex vivo cell therapy. There are only one 
cases in Korea that the intron1-related inversion is cause of 
Haemophilia A. The blood samples of Haemophilia A patient are 
obtained at Korea Haemophilia Foundation Clinic. The genomic DNA is 
isolated from that samples according to the protocols in Materials and 
Methods and, using inversion-specific PCR, genomic inversion events 
were confirmed as in Figure 10. 
  But it is very difficult to isolate transfectable cells from haemophilia 
A patient blood samples. As the second best plan, primary blood cells 
from normal male were used to perform ZFN-mediated genomic 
inversion. As in Figure 9., there are cellular toxicity according to the 
doses of ZFNs. ZFN-treated cells were analyzed by PCR to confirm 
inversion events. As shown in Figure 9., it is possible to induce 
genomic inversion in primary human blood cells.
  ZFN technology is good tools for gene therapy. Here in this study, 
It is demonstrated that ZFN can induce targeted genomic inversion in 
intron 1 of F8 gene, cause of severe haemophilia A. The frequencies 
of inversion in cultured human cells are 0.25%. The same ZFN pair 
are used to induce genomic inversion in primary human blood cells and 
can induce genomic inversion. This results holds new promisea for gene 
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and cell therapy. As discussed above, ZFN technology with iPSCs 
technology is powerful tools for ex vivo cell therapy.
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IV. Figures and Tables







Figure 2. Schematic overview of PCR-based inversion
detectionmethod.
PCR primers(F1,F2,R1andR2)usedtodetecttheinversion are

















meanssharkey DS-RR combination and RD meanssharkey RR-DS
combination.
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Figure 6. DNA sequences of breakpoint junctions of
inversionevents.
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Figure9.Z10-mediated inversion in primary human blood
cels.
Z10 are treated in primary human blood cels by eletroporation.
Inversion eventsaredetected by PCR method using primersetsin
Figure2.
Figure10.HaemophiliaA patient.
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유 체 상의 염기 서열 분석 방법이 속도로 발달하면서,최근 유 체
상의 구조 변이에 한 연구가 활발히 진행되고 있다.일반 으로 구조 변
이는 단일 유 자 변이(SNP)보다 범 하게 일어나는 기작으로 유 체
상의 삽입,결실, 복, 좌,그리고 역 등이 있다.이러한 구조 변이
는 평범한 사람들의 유 체 상에서 일부 보여 지고 있지만,많은 경우에는
실제로 유 병을 발병시키는 원인이 되기도 한다.특히 유 체 상의 역
에 의해서, 우병을 비롯한 헌터 증후군 등이 발병된다고 보고되어 있다.
이러한 이유에서 유 병 치료 분야에서 구조 변이가 주목받고 있지만,
실제 구조 변이에 한 기작 연구에는 어려움이 있었다.실제 유 병을 가
지고 있는 동일한 개체 는 세포 수 에서 손쉽게 구조 변이를 유도할 수
있는 도구가 없었기 때문이다.
본 연구에서는,인간 세포에서 징크 핑거 뉴클 아제 기술을 이용하여
유 체 상에 역 를 일으킬 수 있음을 보이고자 하 다.특히 우병 A유
형의 발병 원인이 되는, 액 응고 인자 8번 유 자 상의 역 를 인 으
로 유도할 수 있는 징크 핑거 뉴클 아제를 만들고 검증해 보았다.이를
통하여 이와 동일한 징크 핑거 뉴클 아제가 우병 A 환자의 세포 치료
에 활용 될 수 있는 가능성을 열었다는데 의미가 있다.본 연구를 바탕으
로 하여 징크 핑거 뉴클 아제 기술이,유 병 치료 분야에서 리 이용되
고 연구되기를 바라는 바이다.
주요어 : 징크핑거뉴클 아제(ZFN), 이 가닥손상(DSB), 구조 변이
(SVs), 유 체 역 , 우병 A, F8 유 자.
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